AngioDynamics

AngioDynamics Revenue per Employee

The Revenue per Employee of AngioDynamics (ANGO) as of Nov 4, 2026 is 506,604.43 USD. In the previous year, Revenue per Employee was 462,813.29 USD — a change of 9.46% (higher).

Revenue per Employee

506,604.43USD

YoY

9.46%

Last updated:

Revenue per Employee of AngioDynamics is 2026 506,604.43 USD. Revenue per Employee of AngioDynamics was 2025 462,813.29 USD. It decreases by 9.46% higher compared to the previous year.

The AngioDynamics Revenue per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Employee
Date
Revenue per Employee
Jan 1, 2019
568,803.80 USD
Jan 1, 2020
417,969.94 USD
Jan 1, 2021
460,458.86 USD
Jan 1, 2022
500,346.52 USD
Jan 1, 2023
536,000.00 USD
Jan 1, 2024
480,876.58 USD
Jan 1, 2025
462,813.29 USD
Jan 1, 2026
506,604.43 USD
The AngioDynamics Revenue per Employee history
YEARRevenue per EmployeeYoY
506,604.43USD+9.46%
462,813.29USD-3.76%
480,876.58USD-10.28%
536,000.00USD+7.13%
500,346.52USD+8.66%
460,458.86USD+10.17%
417,969.94USD-26.52%
568,803.80USD+4.41%
544,754.75USD-1.53%
553,232.59USD-1.14%
559,636.08USD-0.92%
564,832.28USD+0.71%
560,846.52USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AngioDynamics Stock analysis

What does AngioDynamics do? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AngioDynamics stock

Revenue per Employee of AngioDynamics is 506,604.43 USD in 2026.

Revenue per Employee of AngioDynamics changed from 462,813.29 USD to 506,604.43 USD, representing a 9.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Employee AngioDynamics since 2006 – with annual values, charts, and detailed analysis.

Revenue per employee measures workforce productivity by dividing total revenue by the number of employees. Higher values indicate more efficient operations.

Revenue per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Revenue per Employee's AngioDynamics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — AngioDynamics

All Key Metrics — AngioDynamics